In a significant shift for the UK’s life sciences sector, Syncona, the Wellcome Trust-backed FTSE 250 investment company, has revealed plans to implement an orderly wind-down of its portfolio assets.
All posts tagged in Syncona
1Article
- Home
- Syncona
Recent Posts
- Nandos KFC and Other Chains Ditch Commitment to Slow Growing Chickens
- Paramount Wins Warner Bros but Challenges Arise for Filmmaking
- Electric Car Charging Stations Overcharge Drivers
- Trump Insiders Accused of Profiting from War After $1 Million Dollar Bet on Iran Attack
- Oil Prices Surge Amid Disruption of Middle Eastern Supply Chains
- Aria Launches Fifty Million Pound AI Chip Testbed Facility
- Wayve Attracts Major Investment Valued at $8.6 Billion Dollars
- Co-op Group Navigates Challenging Retail Landscape
- Denmark’s Pharmaceutical Giant Faces Economic Challenges
- John Lewis Plans To Buy Back Waitrose Supermarkets
- OpenAI Achieves Record Valuation After Major Funding Round
- Advent International Considering Bid for Senior Engineering Group
- Donald Trump Orders Ban on Anthropic Technology Amidst Controversy
- Jim Ratcliffe invests in Ineos Project One chemicals plant despite significant market challenges
- International Airlines Group reports strong financial results and plans significant share buyback
- Heathrow Airport Third Runway Estimated Cost Nears One Million Pounds Per Metre
- Barclays Faces Scrutiny After MultiMillion Pound Exposure to Loan Provider
- Collapse of Mortgage Lender Unveils Significant Financial Risks
- Rachel Reeves set to collect £40 billion in student loan interest
- Tyrrells Ends Non Potato Vegetable Crisps Range
- Rightmove shares rise as AI threat downplayed
- Paramount Wins Battle for Warner Bros Discovery
- FTSE 100 Marks Record Gains in February
- Trump tariffs push UK businesses closer to China
- Ed Miliband Opens Door to Increased Chinese Investment in UK Energy Sector
- UK Ministry of Defence Approves £1 Billion Helicopter Contract
- Anthropic Seeks to Position Claude as Core Enterprise Infrastructure Rather Than Standalone Tool
- Netflix Walks Away from Warner Bros Bid as Paramount Offers Superior Deal
- Cindy Rose Unveils Strategy to Overhaul WPP
- OpenAI Expands Research Presence in London Amid AI Talent Competition
